A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato Loxapine for Inhalation in Outpatients With Migraine Headache.
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Loxapine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 11 Nov 2009 Results reported in a Alexza Pharmaceuticals media release.
- 14 Sep 2009 Primary endpoint 'Pain relief at 2h' has not been met, according to an Alexza media release.
- 14 Sep 2009 Interim results reported in an Alexza media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History